News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No market-moving headlines were published in the past hour.
  • No major economic data or central bank statements were released in the past hour.
  • No new geopolitical developments or conflict updates were reported in the past hour.
  • No significant corporate earnings, M&A, or analyst actions were announced in the past hour.
  • No noteworthy legislative or political announcements occurred in the past hour.
  • No material commodity, FX, or market-disruption events were reported in the past hour.

Latest Articles

BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026

BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026

BridgeBio Pharma announced presentations at the HFSA Annual Scientific Meeting 2026 showcasing new data on Acoramidis (Attruby®), their oral treatment for transthyretin amyloid cardiomyopathy (ATTR-CM). The data reinforce Acoramidis's clinical profile as a near-complete stabilizer of transthyretin, supporting its position as the first-line therapy …

BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting

BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting

BridgeBio Pharma announced it will present additional Phase 3 CALIBRATE trial data for encaleret, a treatment for autosomal dominant hypocalcemia type 1 (ADH1), at the ASBMR 2026 Annual Meeting. The data includes effects on patient-reported outcomes, bone turnover, and safety profile insights. The trial results and family genetic testing model aim …

FirstService to Announce Third Quarter Results on October 22, 2026

FirstService to Announce Third Quarter Results on October 22, 2026

FirstService Corporation, a leading North American property services company, will release its third quarter 2026 financial results on October 22, 2026. The company will host a conference call to discuss the results, featuring CEO D. Scott Patterson and CFO Jeremy Rakusin. The results will be available via press release and webcast on the company's…

TWG Announces Receipt of Nasdaq Minimum Bid Price Notification

TWG Announces Receipt of Nasdaq Minimum Bid Price Notification

Top Wealth Group Holding Limited announced it received a Nasdaq notification for not meeting the minimum $1.00 bid price requirement over the last 30 consecutive business days. The company has 180 days to regain compliance or face potential delisting, with possible measures including a reverse stock split. The firm specializes in premium sturgeon c…

VCI Global Launches VGAIN Compute AI Token Platform, Expanding into AI Infrastructure and LLM Services

VCI Global Launches VGAIN Compute AI Token Platform, Expanding into AI Infrastructure and LLM Services

VCI Global Limited has launched VGAIN Compute, an AI token platform developed by its subsidiary V Gallant Limited, providing users access to multiple large language models including OpenAI GPT, Meta Llama, and others via token purchase. This platform integrates AI infrastructure with end-user demand, targeting a range of applications such as conten…

AT&T: Subscriber Momentum + Cheap Multiple = Asymmetrical Risk/Reward

AT&T: Subscriber Momentum + Cheap Multiple = Asymmetrical Risk/Reward

AT&T is posting durable subscriber growth in fiber and fixed wireless while trading at single-digit multiples. On a market-cap basis the company generates roughly $13.3B in free cash flow, implying a high-single-digit FCF yield and a 4.6% dividend yield. We like a tactical long into the next earnings/catalyst window with defined risk controls.

Genmab: Epcoritamab Phase 3 Win Creates a Tactical Long Opportunity

Genmab: Epcoritamab Phase 3 Win Creates a Tactical Long Opportunity

Genmab's epcoritamab plus R-CHOP Phase 3 victory in newly diagnosed DLBCL is a step-change catalyst that justifies a tactical long. The stock offers asymmetric upside given a $22.6B market cap, supportive technicals, and still-clear commercialization milestones. Trade plan: enter on a measured pullback, stop below the $34.50 support band, and targe…

Sinclair and New Media to Launch The National Press

Sinclair and New Media to Launch The National Press

Sinclair, Inc. and New Media have launched The National Press, a subscription-based digital news brand leveraging reporting from over 1,200 Sinclair local journalists across more than 60 content centers. The brand will offer free and paid subscriptions via Substack and distribute content through YouTube, podcasts, and social media. This initiative …

Orchid Island Capital To Announce Third Quarter 2026 Results

Orchid Island Capital To Announce Third Quarter 2026 Results

Orchid Island Capital, Inc., a specialty finance REIT investing in Agency RMBS, announced it will release its Q3 2026 financial results after market close on October 22, 2026, followed by an earnings call on October 23, 2026. The company focuses on investing in traditional and structured Agency RMBS, managed by Bimini Advisors.

Toll Brothers Announces Everstead Now Open in Cary, North Carolina

Toll Brothers Announces Everstead Now Open in Cary, North Carolina

Toll Brothers, a leading US luxury homebuilder, announced the grand opening of Everstead, a new community of oversized luxury townhomes in Cary, North Carolina. The development features spacious, low-maintenance homes with multiple designs, modern amenities, and convenient access to top schools and employment centers. Pre-model sales are underway, …

SCWorx Announces Nasdaq Trading to Resume October 7, 2026

SCWorx Announces Nasdaq Trading to Resume October 7, 2026

SCWorx Corp., a healthcare data management solutions provider, announced that its common stock will be reinstated for trading on the Nasdaq Stock Market effective October 7, 2026. The move follows a period of non-trading, reflecting positively on the company's operational progress and ongoing efforts to create shareholder value. The company remains…

Palantir's AI Momentum: A Tactical Long with Conviction

Palantir's AI Momentum: A Tactical Long with Conviction

Palantir is trading at $192.47 with a $462.5B market cap and stretched multiples, but fundamentals - sticky government contracts, accelerating commercial wins, improving cash flow - and technical momentum make a calculated long trade appealing. This idea lays out entry, stop, targets, catalysts and the risks that could derail the thesis.

Rising U.S. Gas Prices Threaten LNG Competitiveness, Industry Leaders Say

Rising U.S. Gas Prices Threaten LNG Competitiveness, Industry Leaders Say

Senior industry figures speaking at a panel at Rice University's Baker Institute said rising U.S. natural gas prices could reduce the competitiveness of American liquefied natural gas projects. Fulcrum LNG's CEO warned that Henry Hub benchmark levels may reach a point that makes U.S. LNG less attractive, while other executives highlighted stable do…

Tradeweb: A Practical Long Trade on Durable Electronic-trading Growth

Tradeweb: A Practical Long Trade on Durable Electronic-trading Growth

Tradeweb (TW) remains a compelling way to play secular migration of institutional trading to electronic venues. The company combines high margins, strong free cash flow and recurring client relationships. This trade idea outlines a long entry at $105.00, a stop at $95.00 and a target of $125.00 over a long-term (180 trading days) horizon, with expl…

Buy Micron: Structural Tightness in Memory Should Lift Shares Through 2028

Buy Micron: Structural Tightness in Memory Should Lift Shares Through 2028

Micron is the memory bellwether: rising AI/data-center demand plus constrained industry capacity make the current pullback a buying opportunity. Balance-sheet strength, $26.2B in free cash flow and double-digit operating leverage support a path to materially higher earnings and a $1,400 stock target over the next 180 trading days if market conditio…